文献速递临床试验与 GCP基础与转化研究

综合康复方案联合化疗对术后非小细胞肺癌患者生活质量的影响:多中心随机临床试验研究方案

The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial.
PubMed 文献 · Trials · 2020-04-03

本研究为多中心随机对照试验,计划纳入354例Ib-IIIa期术后非小细胞肺癌患者,随机分为三组:中药加六字诀运动组、中药加康复教育组、安慰剂加康复教育组,均接受四周期铂类双药辅助化疗。主要结局为EORTC-QLQ-C43量表评估的生活质量,次要结局包括2年无病生存率、无病生存期、中医症状、肿瘤标志物、安全性和不良事件。

要点

  • 中药联合六字诀运动或康复教育,对比安慰剂加康复教育,评估对术后NSCLC化疗患者生活质量的影响。
  • 主要结局为EORTC-QLQ-C43量表每周期评估的生活质量。
  • 次要结局包括2年无病生存率、无病生存期、中医症状、肿瘤标志物、安全性和不良事件。

核心结论

  • 本试验旨在比较中药联合六字诀运动、中药联合康复教育与安慰剂联合康复教育对术后NSCLC辅助化疗患者生活质量的影响。

研究设计与样本

  • 多中心、随机、三臂平行对照临床试验,计划纳入354例Ib-IIIa期术后非小细胞肺癌患者,来自中国五个中心。
  • 患者按1:1:1比例随机分为干预组A(中药加六字诀运动)、干预组B(中药加康复教育)和对照组(安慰剂加康复教育)。
  • 各组均接受铂类双药辅助化疗共四周期;中药颗粒每日服用,六字诀运动每周四次,均在化疗期间进行。

关键数值与推荐

  • 主要结局为生活质量,采用欧洲癌症研究与治疗组织EORTC-QLQ-C43量表每周期评估。
  • 次要结局包括2年无病生存率、无病生存期、中医症状、肿瘤标志物、安全性和不良事件。
  • 治疗后2年内每3个月随访一次,2年后每6个月随访一次,直至疾病复发和/或转移。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Comprehensive rehabilitation therapy based on traditional Chinese medicine (TCM) has been widely applied in various cancer treatments in China. Thus far, Chinese herbal medicine (CHM) has been shown effective in reducing the adverse effects of chemotherapy and improving the quality of life (QoL) during chemotherapy. The purpose of the present study is to compare the effects of CHM plus Liu Zi Jue (LZJ) exercises with CHM plus rehabilitation education and with placebo plus rehabilitation education in patients who have undergone complete resection for nonsmall-cell lung cancer (NSCLC) followed by postoperative adjuvant chemotherapy. METHODS AND DESIGN: A multicenter, randomized clinical trial will be performed with 354 stage Ib-IIIa NSCLC patients in five centers in China. Patients satisfying the inclusion criteria will be randomly divided into three groups according to a 1:1:1 ratio: intervention group A (IGA), intervention group B (IGB), and control group (CG). Each group will receive adjuvant platinum-based doublet chemotherapy for a total of four cycles. IGA participants will receive chemotherapy combined with CHM and LZJ exercises, IGB participants will receive chemotherapy combined with CHM and rehabilitation education, and CG participants will receive chemotherapy combined with placebo and rehabilitation education. The herbal treatment patients will be given granules daily and LZJ exercises will be performed four times per week during chemotherapy. The primary outcome is QoL, which will be assessed with the European Organization for Research and Treatment of Cancer (EORTC)-QLQ-C43 scale in each cycle. The secondary outcomes include the 2-year disease-free survival rate, disease-free survival, TCM symptoms, tumor markers, safety, and adverse events. After treatment, the patients will be followed up every 3 months within 2 years and every 6 months after 2 years until disease recurrence and/or metastasis. DISCUSSION: Our previous study reported that CHM in combination with chemotherapy could lower the overall incidence of adverse events but increased digestive and gastrointestinal side effects compared with chemotherapy alone in postoperative NSCLC patients. This study will lay a foundation for the effectiveness of chemotherapy with or without a comprehensive rehabilitation program for QoL in patients with postoperative NSCLC. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03372694. Retrospectively registered on 17 December 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Yao J, Jiao L, Yao Y, et al. The effect of comprehensive rehabilitation program plus chemotherapy on quality of life in patients with postoperative non-small-cell lung cancer: study protocol of a multicenter randomized clinical trial. Trials. 2020. PMID: 32245480. doi:10.1186/s13063-020-4162-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。